Advertisement
Review article| Volume 298, ISSUE 1-2, P1-10, November 15, 2010

Download started.

Ok

Perspectives of Kennedy's disease

Published:September 16, 2010DOI:https://doi.org/10.1016/j.jns.2010.08.025

      Abstract

      Kennedy's disease, also known as bulbospinal muscular atrophy (BSMA), is a rare, adult-onset, X-linked, recessive trinucleotide, polyglutamine (poly-G) disorder, caused by expansion of an unstable CAG-tandem-repeat in exon 1 of the androgen-receptor (AR) gene on chromosome Xq11-12. Poly-Q-expanded AR accumulates in nuclei, undergoes fragmentation and initiates degeneration and loss of motor neurons and dorsal root ganglia. Phenotypically, patients present with weakness and wasting of the facial, bulbar and extremity muscles, sensory disturbances, and endocrinological disturbances, such as gynecomastia and reduced fertility. In the limb muscles weakness and wasting may be symmetric or asymmetric, proximal or distal, or may predominate at the lower or upper limb muscles. There may be mild to severe hyper-CK-emia, elevated testosterone or other sexual hormones, abnormal motor and sensory nerve conduction studies, and neuropathic or rarely myopathic alterations on muscle biopsy. BSMA is diagnosed if the number of CAG-repeats exceeds 40. No causal therapy is available but symptomatic therapy may be beneficial for weakness, tremor, endocrinological abnormalities, muscle cramps, respiratory failure, or dysphagia. The course is slowly progressive and the ability to walk lost only late in life. Only few patients require ventilatory support and life expectancy is only slightly compromised.

      Abbreviations:

      17-AAG (17-allyl-amino-17-demethoxy-geldanamycin), AR (Androgen-receptor), ASC-J9 (1,7-bis(3,4-dimethoxyphenyl)-5-hydroxy-1E,4E,6E-heptatriene-3-one), BSMA (Bulbospinal muscular atrophy), CBP (cAMP-response element binding protein), CAP-gly (Cytoskeleton-associated protein glycine-rich), CNS (Central nervous system), CSF (Cerebrospinal fluid), CHIP (Cognate hsp70-interacting protein), CMAPs (Compound muscle action potential), CK (Creatine-kinase), CAG (Cytosine–adenosin–guanosin), CREB (CRE-binding protein), DHT (Dihydro-testosterone), 17-DMAG (17-(dimethyl-aminethyl-amino)-17-demethoxy-geldanamycin), EB1 (Microtuble-binding protein), EMG (Electromyography), GGA (Geranyl–geranyl–acetone), HDJ (Co-chaperone of hsp70), HDAC (Histone-deacetylase), HSDJ (Human HSP40 homologue), HSNA (Hereditary sensory and autonomic neuropathy), Hsp (Heat shock protein), JNK (Jun-N-terminal kinase), MUNE (Motor unit number estimation), NEDD (Neuronal precursor cell-expressed developmentally downregulated protein), NLS (Nuclear localization signal), PGC-1 (Peroxisome proliferator-activated receptor gamma coactivator-1), Poly-G (Polyglutamine), Sir2 (Sirtuin 2), SNAP (Sensory nerve action potential), TGF (Tumor growth factor), UPS (Ubiquitine protease system), VEGF (Vascular endothelial growth factor)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sinclair R.
        • Greenland K.J.
        • Egmond S.
        • Hoedemaker C.
        • Chapman A.
        • Zajac J.D.
        Men with Kennedy disease have a reduced risk of androgenetic alopecia.
        Br J Dermatol. 2007; 157: 290-294
        • Jordan C.L.
        • Lieberman A.P.
        Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?.
        Curr Opin Pharmacol. 2008; 8: 752-758
        • Li X.H.
        • Zhuang J.J.
        • Xie Q.Y.
        • Li A.P.
        • Liang X.L.
        • Feng Y.Q.
        • et al.
        Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases.
        Zhonghua Yi Xue Za Zhi. 2007; 87: 1611-1615
        • Thomas Jr, P.S.
        • Fraley G.S.
        • Damian V.
        • Woodke L.B.
        • Zapata F.
        • Sopher B.L.
        • et al.
        Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
        Hum Mol Genet. 2006; 15: 2225-2238
        • Kennedy W.R.
        • Alter M.
        • Sung J.H.
        Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.
        Neurology. 1968; 18: 671-680
      1. Barkhaus E. Kennedy disease. E-Medicine. http://emedicine.medscape.com/article/ 1172604-overview, 2010.

        • Schoenen J.
        • Delwaide P.J.
        • Legros J.J.
        • Franchimont P.
        Hereditary motor neuron disease: the proximal, adult, sex-linked form (or Kennedy disease). Clinical and neuroendocrinologic observations.
        J Neurol Sci. 1979; 41: 343-357
        • Fischbeck K.H.
        • Ionasescu V.
        • Ritter A.W.
        • Ionasescu R.
        • Davies K.
        • Ball S.
        • et al.
        Localization of the gene for X-linked spinal muscular atrophy.
        Neurology. 1986; 36: 1595-1598
        • La Spada A.R.
        • Wilson E.M.
        • Lubahn D.B.
        • Harding A.E.
        • Fischbeck K.H.
        Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.
        Nature. 1991; 352: 77-79
        • Igarashi S.
        • Tanno Y.
        • Onodera O.
        • Yamazaki M.
        • Sato S.
        • Ishikawa A.
        • et al.
        Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy.
        Neurology. 1992; 42: 2300-2302
        • Bingham P.M.
        • Scott M.O.
        • Wang S.
        • McPhaul M.J.
        • Wilson E.M.
        • Garbern J.Y.
        • et al.
        Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice.
        Nat Genet. 1995; 9: 191-196
        • Walcott J.L.
        • Merry D.E.
        Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy.
        Vitam Horm. 2002; 65: 127-147
        • Katsuno M.
        • Adachi H.
        • Doyu M.
        • Minamiyama M.
        • Sang C.
        • Kobayashi Y.
        • et al.
        Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
        Nat Med. 2003; 9: 768-773
        • Puls I.
        • Oh S.J.
        • Sumner C.J.
        • Wallace K.E.
        • Floeter M.K.
        • Mann E.A.
        • et al.
        Distal spinal and bulbar muscular atrophy caused by dynactin mutation.
        Ann Neurol. 2005; 57: 687-694
        • Guidetti D.
        • Sabadini R.
        • Ferlini A.
        • Torrente I.
        Epidemiological survey of X-linked bulbar and spinal muscular atrophy, or Kennedy disease, in the province of Reggio Emilia, Italy.
        Eur J Epidemiol. 2001; 17: 587-591
        • Udd B.
        • Juvonen V.
        • Hakamies L.
        • Nieminen A.
        • Wallgren-Pettersson C.
        • Cederquist K.
        • et al.
        High prevalence of Kennedy's disease in Western Finland—is the syndrome underdiagnosed?.
        Acta Neurol Scand. 1998; 98: 128-133
        • Neuromuscular disease center
        Washington University, St. Louis, Montana, USA2010 (http://neuromuscular.wustl.edu.)
        • Echaniz-Laguna A.
        • Bousiges O.
        • Loeffler J.P.
        • Boutillier A.L.
        Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases.
        Curr Med Chem. 2008; 15: 1263-1273
        • Karaer H.
        • Kaplan Y.
        • Kurt S.
        • Gundogdu A.
        • Erdoğan B.
        • Basak N.A.
        Phenotypic differences in a large family with Kennedy's disease from the Middle Black Sea region of Turkey.
        Amyotroph Lateral Scler. 2008; 9: 1-6
        • Atsuta N.
        • Watanabe H.
        • Ito M.
        • Banno H.
        • Suzuki K.
        • Katsuno M.
        • et al.
        Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.
        Brain. 2006; 129: 1446-1455
        • Sperfeld A.D.
        • Karitzky J.
        • Brummer D.
        • Schreiber H.
        • Häussler J.
        • Ludolph A.C.
        • et al.
        X-linked bulbospinal neuronopathy: Kennedy disease.
        Arch Neurol. 2002; 59: 1921-1926
      2. La Spada AR Spinal and Bulbar Muscular Atrophy. 1999 Feb 26 [updated 2006 Dec 28]. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=kennedy.

        • Lee J.H.
        • Shin J.H.
        • Park K.P.
        • Kim I.J.
        • Kim C.M.
        • Lim J.G.
        • et al.
        Phenotypic variability in Kennedy's disease: implication of the early diagnostic features.
        Acta Neurol Scand. 2005; 112: 57-63
        • Tomik B.
        • Partyka D.
        • Sułek A.
        • Kurek-Gryz E.A.
        • Banach M.
        • Ostrowska M.
        • et al.
        A phenotypic-genetic study of a group of Polish patients with spinal and bulbar muscular atrophy.
        Amyotroph Lateral Scler. 2006; 7: 72-79
        • Rhodes L.E.
        • Freeman B.K.
        • Auh S.
        • Kokkinis A.D.
        • La Pean A.
        • Chen C.
        • et al.
        Clinical features of spinal and bulbar muscular atrophy.
        Brain. 2009; 132: 3242-3251
        • Suzuki K.
        • Katsuno M.
        • Banno H.
        • Takeuchi Y.
        • Atsuta N.
        • Ito M.
        • et al.
        CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
        Brain. 2008; 131: 229-239
        • Badalian L.O.
        • Temin P.A.
        • Arkhipov B.A.
        • Zavadenko N.N.
        • Bulaeva N.V.
        • Lysov V.L.
        Familial case of late recessive X-linked Kennedy's spinal and bulbar amyotrophy.
        Zh Nevropatol Psikhiatr Im S S Korsakova. 1989; 89: 39-44
        • Larsen K.
        • Smith T.A.
        “Jaw drop” as an atypical manifestation of Kennedy's disease.
        Ugeskr Laeger. 2005; 167: 3310-3311
        • Lai T.H.
        • Soong B.W.
        • Chen J.T.
        • Chen Y.Y.
        • Lai K.L.
        • Wu Z.A.
        • et al.
        Multimodal evoked potentials of Kennedy's disease.
        Can J Neurol Sci. 2007; 34: 328-332
        • Battaglia F.
        • Le Galudec V.
        • Cossee M.
        • Tranchant C.
        • Warter J.M.
        • Echaniz-Laguna A.
        Kennedy's disease initially manifesting as an endocrine disorder.
        J Clin Neuromuscul Dis. 2003; 4: 165-167
        • Harding A.E.
        • Thomas P.K.
        • Baraitser M.
        • Bradbury P.G.
        • Morgan-Hughes J.A.
        • Ponsford J.R.
        X-linked recessive bulbospinal neuronopathy: a report of ten cases.
        J Neurol Neurosurg Psychiatry. 1982; 45: 1012-1019
        • Thurtell M.J.
        • Pioro E.P.
        • Leigh R.J.
        Abnormal eye movements in Kennedy disease.
        Neurology. 2009; 72: 1528-1530
        • Finsterer J.
        • Stöllberger C.
        Quinine-responsive muscle cramps in X-linked bulbospinal muscular atrophy Kennedy.
        J Neurol. 2009; 256: 1355-1356
        • Praline J.
        • Guennoc A.M.
        • Malinge M.C.
        • de Toffol B.
        • Corcia P.
        Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene.
        Amyotroph Lateral Scler. 2008; 9: 40-42
        • Warnecke T.
        • Oelenberg S.
        • Teismann I.
        • Suntrup S.
        • Hamacher C.
        • Young P.
        • et al.
        Dysphagia in X-linked bulbospinal muscular atrophy (Kennedy disease).
        Neuromuscul Disord. 2009; 19: 704-708
        • Banno H.
        • Katsuno M.
        • Suzuki K.
        • Tanaka F.
        • Sobue G.
        Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.
        Int J Mol Sci. 2009; 10: 1000-1012
        • Pachatz C.
        • Terracciano C.
        • Desiato M.T.
        • Orlacchio A.
        • Mori F.
        • Rocchi C.
        • et al.
        Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy.
        Clin Neurophysiol. 2007; 118: 262-268
        • Mirowska-Guzel D.
        • Seniow J.
        • Sułek A.
        • Leśniak M.
        • Członkowska A.
        Are cognitive and behavioural deficits a part of the clinical picture in Kennedy's disease? A case study.
        Neurocase. 2009; 15: 332-337
        • Sorenson E.J.
        • Klein C.J.
        Elevated creatine kinase and transaminases in asymptomatic SBMA.
        Amyotroph Lateral Scler. 2007; 8: 62-64
        • Weber M.
        • Ferreira V.
        • Eisen A.
        Determinants of double discharges in amyotrophic lateral sclerosis and Kennedy disease.
        Clin Neurophysiol. 2009; 120: 1971-1977
        • Meriggioli M.N.
        • Rowin J.
        Fatigue and abnormal neuromuscular transmission in Kennedy's disease.
        Muscle Nerve. 2003; 27: 249-251
        • Hamano T.
        • Mutoh T.
        • Hirayama M.
        • Kawamura Y.
        • Nagata M.
        • Fujiyama J.
        • et al.
        Muscle MRI findings of X-linked spinal and bulbar muscular atrophy.
        J Neurol Sci. 2004; 222: 93-97
        • Sorarù G.
        • D'Ascenzo C.
        • Polo A.
        • Palmieri A.
        • Baggio L.
        • Vergani L.
        • et al.
        Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.
        J Neurol Sci. 2008; 264: 100-105
        • Doyu M.
        • Sobue G.
        • Mitsuma T.
        • Uchida M.
        • Iwase T.
        • Takahashi A.
        Very late onset X-linked recessive bulbospinal neuronopathy: mild clinical features and a mild increase in the size of tandem CAG repeat in androgen receptor gene.
        J Neurol Neurosurg Psychiatry. 1993; 56: 832-833
        • Adachi H.
        • Waza M.
        • Tokui K.
        • Katsuno M.
        • Minamiyama M.
        • Tanaka F.
        • et al.
        C overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
        J Neurosci. 2007; 27: 5115-5126
        • Banno H.
        • Adachi H.
        • Katsuno M.
        • Suzuki K.
        • Atsuta N.
        • Watanabe H.
        • et al.
        Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
        Ann Neurol. 2006; 59: 520-526
        • Banno H.
        • Katsuno M.
        • Suzuki K.
        • Takeuchi Y.
        • Kawashima M.
        • Suga N.
        • et al.
        Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
        Ann Neurol. 2009; 65: 140-150
        • Schmidt B.J.
        • Greenberg C.R.
        • Allingham-Hawkins D.J.
        • Spriggs E.L.
        Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women.
        Neurology. 2002; 59: 770-772
        • Paradas C.
        • Solano F.
        • Carrillo F.
        • Fernández C.
        • Bautista J.
        • Pintado E.
        • et al.
        Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy's disease).
        J Neurol. 2008; 255: 853-857
        • Palazzolo I.
        • Gliozzi A.
        • Rusmini P.
        • Sau D.
        • Crippa V.
        • Simonini F.
        • et al.
        The role of the polyglutamine tract in androgen receptor.
        J Steroid Biochem Mol Biol. 2008; 108: 245-253
        • Montie H.L.
        • Merry D.E.
        Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA.
        Autophagy. 2009; 5: 1194-1197
        • Davies P.
        • Watt K.
        • Kelly S.M.
        • Clark C.
        • Price N.C.
        • McEwan I.J.
        Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain.
        J Mol Endocrinol. 2008; 41: 301-314
        • Brown C.J.
        • Goss S.J.
        • Lubahn D.B.
        • Joseph D.R.
        • Wilson E.M.
        • French F.S.
        • et al.
        Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism.
        Am J Hum Genet. 1989; 44: 264-269
        • Manning J.T.
        The androgen receptor gene: a major modifier of speed of neuronal transmission and intelligence?.
        Med Hypotheses. 2007; 68: 802-804
        • Doyu M.
        • Sobue G.
        • Mukai E.
        • Takahashi A.
        • Mitsuma T.
        DNA diagnosis of X-linked recessive bulbospinal muscular atrophy by androgen receptor gene mutations.
        Rinsho Shinkeigaku. 1992; 32: 336-339
        • Amato A.A.
        • Prior T.W.
        • Barohn R.J.
        • Snyder P.
        • Papp A.
        • Mendell J.R.
        Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene.
        Neurology. 1993; 43: 791-794
        • Rosales-Reynoso M.A.
        • Ochoa-Hernández A.B.
        • Barros-Núñez P.
        Diseases caused by triplet expansion.
        Rev Neurol. 2009; 49: 79-87
        • Ahmed S.
        • Sun S.
        • Siglin A.E.
        • Polenova T.
        • Williams J.C.
        Disease-Associated Mutations in the p150(Glued) subunit destabilize the CAP-gly domain.
        Biochemistry. 2010; 49: 5083-5085
        • Katsuno M.
        • Banno H.
        • Suzuki K.
        • Takeuchi Y.
        • Kawashima M.
        • Tanaka F.
        • et al.
        Molecular genetics and biomarkers of polyglutamine diseases.
        Curr Mol Med. 2008; 8: 221-234
        • Yamada M.
        • Sato T.
        • Tsuji S.
        • Takahashi H.
        CAG repeat disorder models and human neuropathology: similarities and differences.
        Acta Neuropathol. 2008; 115: 71-86
        • Zhou Y.F.
        • Jiang H.
        • Tang J.G.
        • Tang B.S.
        The advances in research on phosphorylation of polyglutamine disease.
        Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008; 25: 414-417
        • Palazzolo I.
        • Burnett B.G.
        • Young J.E.
        • Brenne P.L.
        • La Spada A.R.
        • Fischbeck K.H.
        • et al.
        Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity.
        Hum Mol Genet. 2007; 16: 1593-1603
        • LaFevre-Bernt M.A.
        • Ellerby L.M.
        Kennedy's disease. Phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death.
        J Biol Chem. 2003; 278: 34918-34924
        • Katsuno M.
        • Adachi H.
        • Minamiyama M.
        • Waza M.
        • Doi H.
        • Kondo N.
        • et al.
        Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy.
        J Neurosci. 2010; 30: 5702-5712
        • Young J.E.
        • Garden G.A.
        • Martinez R.A.
        • Tanaka F.
        • Sandoval C.M.
        • Smith A.C.
        • et al.
        Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk.
        J Neurosci. 2009; 29: 1987-1997
        • Suzuki E.
        • Zhao Y.
        • Ito S.
        • Sawatsubashi S.
        • Murata T.
        • Furutani T.
        • et al.
        Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.
        Proc Natl Acad Sci USA. 2009; 106: 3818-3822
        • Ranganathan S.
        • Harmison G.G.
        • Meyertholen K.
        • Pennuto M.
        • Burnett B.G.
        • Fischbeck K.H.
        • et al.
        Mitochondrial abnormalities in spinal and bulbar muscular atrophy.
        Hum Mol Genet. 2010; 18: 27-42
        • Liu C.S.
        • Cheng W.L.
        • Kuo S.J.
        • Li J.Y.
        • Soong B.W.
        • Wei Y.H.
        Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases.
        J Neurol Sci. 2008; 264: 18-21
        • Katsuno M.
        • Adachi H.
        • Minamiyama M.
        • Waza M.
        • Tokui K.
        • Banno H.
        • et al.
        Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.
        J Neurosci. 2006; 26: 12106-12117
        • Sobue G.
        • Hashizume Y.
        • Mukai E.
        • Hirayama M.
        • Mitsuma T.
        • Takahashi A.
        X-linked recessive bulbospinal neuronopathy. A clinicopathological study.
        Brain. 1989; 112: 209-232
        • Adachi H.
        • Katsuno M.
        • Minamiyama M.
        • Waza M.
        • Sang C.
        • Nakagomi Y.
        • et al.
        Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.
        Brain. 2005; 128: 659-670
        • Li M.
        • Sobue G.
        • Doyu M.
        • Mukai E.
        • Hashizume Y.
        • Mitsuma T.
        Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression.
        Muscle Nerve. 1995; 18: 301-308
        • MacLean H.E.
        • Gonzales M.
        • Greenland K.J.
        • Warne G.L.
        • Zajac J.D.
        Age-dependent differences in androgen binding affinity in a family with spinal and bulbar muscular atrophy.
        Neurol Res. 2005; 27: 548-551
        • Goldenberg J.N.
        • Bradley W.G.
        Testosterone therapy and the pathogenesis of Kennedy's disease (X-linked bulbospinal muscular atrophy).
        J Neurol Sci. 1996; 135: 158-161
        • Kinirons P.
        • Rouleau G.A.
        Administration of testosterone results in reversible deterioration in Kennedy's disease.
        J Neurol Neurosurg Psychiatry. 2008; 79: 106-107
        • Katsuno M.
        • Adachi H.
        • Tanaka F.
        • Sobue G.
        Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
        J Mol Med. 2004; 82: 298-307
        • Shimohata T.
        • Kimura T.
        • Nishizawa M.
        • Onodera O.
        • Tsuji S.
        Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin.
        J Neurol Neurosurg Psychiatry. 2004; 75: 1206-1207
        • Minamiyama M.
        • Katsuno M.
        • Adachi H.
        • Waza M.
        • Sang C.
        • Kobayashi Y.
        • et al.
        Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.
        Hum Mol Genet. 2004; 13: 1183-1192
        • Katsuno M.
        • Sang C.
        • Adachi H.
        • Minamiyama M.
        • Waza M.
        • Tanaka F.
        • et al.
        Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease.
        Proc Natl Acad Sci USA. 2005; 102: 16801-16806
        • Howarth J.L.
        • Kelly S.
        • Keasey M.P.
        • Glover C.P.
        • Lee Y.B.
        • Mitrophanous K.
        • et al.
        Hsp40 molecules that target to the ubiquitin–proteasome system decrease inclusion formation in models of polyglutamine disease.
        Mol Ther. 2007; 15: 1100-1105
        • Adachi H.
        • Katsuno M.
        • Minamiyama M.
        • Sang C.
        • Pagoulatos G.
        • Angelidis C.
        • et al.
        Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.
        J Neurosci. 2003; 23: 2203-2211
        • Tokui K.
        • Adachi H.
        • Waza M.
        • Katsuno M.
        • Minamiyama M.
        • Doi H.
        • et al.
        17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
        Hum Mol Genet. 2009; 18: 898-910
        • Waza M.
        • Adachi H.
        • Katsuno M.
        • Minamiyama M.
        • Sang C.
        • Tanaka F.
        • et al.
        17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
        Nat Med. 2005; 11: 1088-1095
        • Yang Z.
        • Chang Y.J.
        • Yu I.C.
        • Yeh S.
        • Wu C.C.
        • Miyamoto H.
        • et al.
        ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.
        Nat Med. 2007; 13: 348-353
        • Rusmini P.
        • Sau D.
        • Crippa V.
        • Palazzolo I.
        • Simonini F.
        • Onesto E.
        • et al.
        Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy.
        Neurobiol Aging. 2007; 28: 1099-1111
        • Chahin N.
        • Klein C.
        • Mandrekar J.
        • Sorenson E.
        Natural history of spinal-bulbar muscular atrophy.
        Neurology. 2008; 70: 1967-1971
        • Takeuchi Y.
        • Katsuno M.
        • Banno H.
        • Suzuki K.
        • Kawashima M.
        • Atsuta N.
        • et al.
        Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy.
        Muscle Nerve. 2008; 38: 964-971
        • Monks D.A.
        • Rao P.
        • Mo K.
        • Johansen J.A.
        • Lewis G.
        • Kemp M.Q.
        Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy.
        Horm Behav. 2008; 53: 729-740